![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Bladder Cancer |
Free Subscription
1 Am J Clin Exp Urol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Depression and anxiety among patients treated for bladder cancer: examining
clinical, demographic, and psychosocial predictors.
Am J Clin Exp Urol. 2023;11:401-413.
PubMed
Abstract available
High-precision bladder cancer diagnosis method: 2D Raman spectrum figures based
on maintenance technology combined with automatic weighted feature fusion
network.
Anal Chim Acta. 2023;1282:341908.
PubMed
Abstract available
Retracted: Applications of Bladder Cancer Data Using a Modified Log-Logistic
Model.
Appl Bionics Biomech. 2023;2023:9789308.
PubMed
Abstract available
A carcinoma in situ was inadvertently discovered after surgery for urinary
bladder contracture.
Asian J Surg. 2023;46:4897-4898.
PubMed
Pelvic lipomatosis with mucinous adenocarcinoma: A case report and literature
review.
Asian J Surg. 2023;46:4889-4890.
PubMed
Differentiation of urothelial carcinoma and neuroendocrine carcinoma in the
urinary bladder based on CT texture analysis.
Asian J Surg. 2023;46:5053-5054.
PubMed
Laparoscopic and Robotic-Assisted Extended Pelvic Lymph Node Dissection for
Invasive Bladder Cancer: A Review.
Bladder (San Franc). 2023;10:e21200004.
PubMed
Abstract available
The diagnostic value of fluorescence in situ hybridization in secondary
electroresection of bladder cancer.
Bladder (San Franc). 2023;10:e21200006.
PubMed
Abstract available
Advances in the bladder cancer research using 3D culture models.
Bladder (San Franc). 2023;10:e21200005.
PubMed
Abstract available
Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for
muscle-invasive bladder cancer: a systematic review and meta-analysis.
BMC Cancer. 2023;23:1066.
PubMed
Abstract available
Application of contrast-enhanced ultrasound in renal space-occupying lesion
puncture biopsy.
BMC Med Imaging. 2023;23:178.
PubMed
Abstract available
Comparative real-world survival outcomes of muscle-invasive bladder cancer
treated with bladder-only vs. whole-pelvis concurrent chemoradiation.
Can Urol Assoc J. 2023 Oct 23. doi: 10.5489/cuaj.8386.
PubMed
Abstract available
Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced
and Metastatic Bladder Cancer.
Cancer Diagn Progn. 2023;3:706-715.
PubMed
Abstract available
Retracted: Computed Tomography Image Features under Deep Learning Algorithm
Applied in Staging Diagnosis of Bladder Cancer and Detection on Ceramide
Glycosylation.
Comput Math Methods Med. 2023;2023:9842436.
PubMed
Abstract available
Ipsilateral synchronous papillary renal neoplasm with reverse polarity and
urothelial carcinoma in a renal transplant recipient: a rare case report with
molecular analysis and literature review.
Diagn Pathol. 2023;18:120.
PubMed
Abstract available
Anoikis-associated signatures predict prognosis and immune response in bladder
cancer.
Epigenomics. 2023 Nov 9. doi: 10.2217/epi-2023-0240.
PubMed
Abstract available
Multiparametric MRI-based VI-RADS: can it predict 1- to 5-year recurrence of
bladder cancer?
Eur Radiol. 2023 Nov 6. doi: 10.1007/s00330-023-10387.
PubMed
Abstract available
Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guerin (BCG) Versus
Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer:
Feasibility Phase of a Randomized Controlled Study.
Eur Urol Focus. 2023 Nov 1:S2405-4569(23)00236-5. doi: 10.1016/j.euf.2023.
PubMed
Abstract available
Small-molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT
dual-inhibiting properties for bladder cancer treatment.
Exploration (Beijing). 2023;3:20220141.
PubMed
Abstract available
POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer.
FASEB J. 2023;37:e23260.
PubMed
Abstract available
LUCAT1 inhibits ferroptosis in bladder cancer by regulating the mRNA stability of
STAT3.
Gene. 2023 Nov 7:147974. doi: 10.1016/j.gene.2023.147974.
PubMed
Abstract available
Selective targeting of lectins and their macropinocytosis in urothelial tumours:
translation from in vitro to ex vivo.
Histochem Cell Biol. 2023;160:435-452.
PubMed
Abstract available
WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer.
Histol Histopathol. 2023 Oct 23:18671. doi: 10.14670.
PubMed
Abstract available
A case of bladder cancer after bilateral lung transplantation following bone
marrow transplantation.
IJU Case Rep. 2023;6:471-474.
PubMed
Abstract available
Radiotherapy combined with deep regional hyperthermia in elderly and frail
patients with muscle-invasive bladder cancer: quality analysis of hyperthermia
and impact on clinical results.
Int J Hyperthermia. 2023;40:2275540.
PubMed
Abstract available
The effect of immediate neoadjuvant electromotive instillation of mitomycin C
with Bacillus Calmette-Guerin versus BCG alone in non-muscle-invasive bladder
cancer: A randomized controlled trial.
Investig Clin Urol. 2023;64:554-560.
PubMed
Abstract available
Accuracy of Vesical Imaging-Reporting and Data System for muscle-invasive bladder
cancer detection from multiparametric magnetic resonance imaging.
Investig Clin Urol. 2023;64:546-553.
PubMed
Abstract available
Impact of rural residence on the presentation, management and survival of
patients with non-metastatic muscle-invasive bladder carcinoma.
Investig Clin Urol. 2023;64:561-571.
PubMed
Abstract available
Differences in clinical features between focal and extensive types of cystitis
glandularis in patients without a previous history of urinary tract malignancy.
Investig Clin Urol. 2023;64:597-605.
PubMed
Abstract available
The Prevalence of p16 Expression in Urothelial Bladder Cancer in a Tertiary Care
Hospital of Chattogram, Bangladesh.
Iran J Pathol. 2023;18:306-311.
PubMed
Abstract available
Alternative polyadenylation-related genetic variants contribute to bladder cancer
risk.
J Biomed Res. 2023 Nov 15:1-13. doi: 10.7555/JBR.37.20230063.
PubMed
Abstract available
MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and
invasion of bladder cancer cells and increases cisplatin sensitivity.
J Cancer Res Clin Oncol. 2023 Nov 8. doi: 10.1007/s00432-023-05484.
PubMed
Abstract available
Primary leiomyoma of the bladder radiologically mimicking a retroperitoneal tumor
- a case report.
J Med Invest. 2023;70.
PubMed
Abstract available
Long-Term Oncological Outcomes in Patients Diagnosed with Non-Metastatic
Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson
Cancer Center Experience.
J Urol. 2023 Nov 3:101097JU0000000000003778. doi: 10.1097/JU.0000000000003778.
PubMed
Abstract available
Peripheral Blasts in a Patient Receiving Chemotherapy.
JAMA. 2023;330:1581-1582.
PubMed
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
N Engl J Med. 2023;389:1778-1789.
PubMed
Abstract available
Cancer trial results show power of weaponized antibodies.
Nature. 2023;623:231-232.
PubMed
Human amniotic membrane inhibits migration and invasion of muscle-invasive
bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR
signalling pathway.
Sci Rep. 2023;13:19227.
PubMed
Abstract available
Screening for a practical method to monitor the status of patients with
metastatic bladder cancer at the circulating cell-gene level.
Sci Rep. 2023;13:19517.
PubMed
Abstract available
Corrigendum to "PRMT5-activated c-Myc promote bladder cancer proliferation and
invasion through up-regulating NF-kappaB pathway" [Tissue Cell 76 (2022) 101788].
Tissue Cell. 2023 Nov 1:102221. doi: 10.1016/j.tice.2023.102221.
PubMed
Quantitative transcriptomic and proteomic analysis reveals corosolic acid
inhibiting bladder cancer via suppressing cell cycle and inducing mitophagy in
vitro and in vivo.
Toxicol Appl Pharmacol. 2023 Nov 6:116749. doi: 10.1016/j.taap.2023.116749.
PubMed
Abstract available
Bladder Cancer and Artificial Intelligence: Emerging Applications.
Urol Clin North Am. 2024;51:63-75.
PubMed
Abstract available
The management of toxicities from immune, targeted and ADCs treatments in
patients with urothelial cancer.
Urol Oncol. 2023;41:410-419.
PubMed
Abstract available
The patient experience with localized upper tract urothelial cancer.
Urol Oncol. 2023;41:431.
PubMed
Abstract available
Antibody-drug conjugates for urothelial carcinoma.
Urol Oncol. 2023;41:420-428.
PubMed
Abstract available
The relationship between BCG immunotherapy and oxidative stress parameters in
patients with nonmuscle invasive bladder cancer.
Urol Oncol. 2023 Nov 4:S1078-1439(23)00321-6. doi: 10.1016/j.urolonc.2023.
PubMed
Abstract available
Conditional survival following radical cystectomy for urothelial carcinoma of the
bladder.
Urol Oncol. 2023;41:432.
PubMed
Abstract available
Feasibility and tissue concordance of genomic sequencing of urinary cytology in
upper tract urothelial carcinoma.
Urol Oncol. 2023;41:433.
PubMed
Abstract available
Preoperative urine sediment chromosomal instability level predicts urothelial
cancer prognosis.
Urol Oncol. 2023;41:433.
PubMed
Abstract available
A new era in the treatment of urothelial carcinoma.
Urol Oncol. 2023;41:395-397.
PubMed
Abstract available
[Antibody-drug conjugates directed against NECTIN-4 as a new treatment option for
patients with metastatic urothelial carcinoma].
Urologie. 2023;62:1193-1199.
PubMed
Abstract available
Does Alexis(c) wound protector/retractor reduce the risk of surgical site
infections after open radical cystectomy for bladder cancer? Results from a
single center, comparative study.
Urology. 2023 Nov 6:S0090-4295(23)00951-2. doi: 10.1016/j.urology.2023.
PubMed
Abstract available
The role of perioperative chemotherapy for upper tract urothelial carcinoma
patients treated with radical nephroureterectomy.
World J Urol. 2023;41:3205-3230.
PubMed
Abstract available
Perioperative, renal function and oncological outcomes of robot-assisted radical
nephroureterectomy for patients with upper tract urothelial carcinoma.
World J Urol. 2023;41:3001-3007.
PubMed
Abstract available
Experts' recommendations in laser use for the treatment of upper tract urothelial
carcinoma: a comprehensive guide by the European Section of Uro-Technology (ESUT)
and Training Research in Urological Surgery and Technology (T.R.U.S.T.) group.
World J Urol. 2023;41:3367-3376.
PubMed
Abstract available
Thank you for your interest in scientific medicine.